Immuron Limited
IMRN
$1.92
$0.10855.99%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 69.54% | 73.52% | 105.81% | 100.72% | 300.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 69.54% | 73.52% | 105.81% | 100.72% | 300.00% |
| Cost of Revenue | 72.49% | 76.52% | 957.24% | 936.01% | 393.36% |
| Gross Profit | 68.10% | 72.05% | 32.03% | 28.79% | 266.03% |
| SG&A Expenses | 43.89% | 47.27% | 36.18% | 32.83% | 14.53% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 62.75% | 61.88% | -42.27% | -38.76% | -11.19% |
| Total Operating Expenses | 49.29% | 52.78% | 111.06% | 105.85% | 76.83% |
| Operating Income | -25.68% | -28.59% | -115.26% | -109.93% | -7.13% |
| Income Before Tax | -20.03% | -22.83% | -165.38% | -158.83% | -3.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -20.03% | -22.83% | -165.38% | -158.83% | -3.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.03% | -22.83% | -165.38% | -158.83% | -3.84% |
| EBIT | -25.68% | -28.59% | -115.26% | -109.93% | -7.13% |
| EBITDA | -25.75% | -28.69% | -115.59% | -111.53% | -7.07% |
| EPS Basic | -16.67% | -20.00% | -159.26% | -159.26% | -3.45% |
| Normalized Basic EPS | -15.79% | -21.05% | -225.00% | -225.00% | -5.56% |
| EPS Diluted | -20.00% | -23.33% | -159.26% | -159.26% | -3.45% |
| Normalized Diluted EPS | -15.79% | -21.05% | -225.00% | -225.00% | -5.56% |
| Average Basic Shares Outstanding | 0.32% | 0.32% | 0.05% | 0.05% | 0.00% |
| Average Diluted Shares Outstanding | 0.32% | 0.32% | 0.05% | 0.05% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |